Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Norfolk, Virginia


Purpose:

To determine the effect of Ruboxistaurin on small fiber function.


Criteria:

Inclusion Criteria: - Patients must have Type 1 or Type 2 diabetes mellitus - Patients must have bilateral sensorimotor distal peripheral neuropathy attributable to diabetes mellitus - Patients must have blood glucose control measured as HbA1c=<11% - Patients must be 18 years of age or older. - Patients must be able to return to all follow-up visits Exclusion Criteria: - Patients must not have symptoms of diabetic peripheral neuropathy that cannot be distinguished from other etiologies - Patients must not have a neurologic disease or neuropathy from a cause other than diabetes mellitus that would interfere with correct evaluation of symptomatic peripheral neuropathy. - Patient currently has uncontrolled high blood pressure - You have other medical problems that your doctor feels would make it unsafe for you to participate in this study such as liver or kidney problems - You are a woman of childbearing age and unwilling or unable to use effective contraceptive.


NCT ID:

NCT00190970


Primary Contact:

Study Director
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon-Fri 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company


Backup Contact:

N/A


Location Contact:

Norfolk, Virginia
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.